From: A randomized, double blind, placebo and active comparator controlled pilot study of UP446, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin
UP446250 mg/day
UP446500 mg/day
Celecoxib200 mg/day
Placebo
Total (N)
15
Mean (SD) Age
62.8 (10.8)
54.6 (14.8)
57.6 (12.6)
55.3 (14.3)
Male N (%)
5 (33)
6 (40)
Female N (%)
10 (67)
9 (60)